Multiple sclerosis: Descriptive study of the clinical forms in 302 cases;Esclerose múltipla: Estudo descritivo de suas formas clínicas em 302 casos

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 2 B, 2000, Pages 460-466

  Moreira, Marcos Aurélio ^a   Felipe, Eduardo ^a   Mendes, Maria Fernanda ^a   Tilbery, Charles Peter ^a  

^a NONE

Author keywords

Descriptive study; Evolutive forms; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGE OF ONSET; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0034198767     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2000000300010     Document Type: Article

References (29)

1. Kurtzke JF, Beebe GW, Dagler B, et al. Studies on the natural history of multiple sclerosis: clinical and laboratory findings at first diagnosis. Acta Neurol Scand 1972;48:19-46.
2. Compston A. Esclerosis multiple. In Brostoff J, Scadding GK, Male DK, Roitt IM (eds). Inmunología clínica. London: Gower Med Publ 1994:9.2-9.7.
3. Fernández O, Fernández VE. Esclerosis múltiple: una enfermedad relativamente frecuente en España. Fundación Española de Esclerosis Múltiple (FEDEM).Málaga, 1997.
4. Hartung HP, Archelos JJ, Zielasek J, et al. Circulating adhesion molecule and inflammatory mediators in demyelination: a review. Neurology 1995;45(S6):S22-S32.
5. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994;36:S15-S17
6. Sadovnick AD. Genetic epidemiology of multiple sclerosis: a survey. Ann Neurol 1994;36(S2):S194-S203.
7. Poser CM. Viking voyages: the origin of multiple sclerosis? An essay in medical history. Acta Neurol Scand 1995;161:11-22.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
9. Kurtzke JF. Raling neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
10. Sipe JC, Knobler RL, Braheny SL, et al. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 1984;34:1368-1372.
11. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis. Neurology 1996;46:907-911.
12. Thompson AJ, Hutchinson M, Brazil J, et al. A clinical and laboratory study of benign multiple sclerosis. Q J Med 1986;58:69-80.
13. Oliveira EML. Estudo retrospectivo de 50 pacientes do ambulatório de doenças neuromusculares da UNIFESP - EPM. no período de 1983-1995. Tese de Mestrado, Escola Paulista de Medicina UNIFESP. São Paulo, 1997.
14. Callegaro D. Contribuição do estudo clínico evolutivo da esclerose múltipla: análise de 120 pacientes. Tese de Doutorado. Faculdade de Medicina da Universidade de São Paulo. São Paulo, 1989.
15. Callegaro D, Lolio CA, Radvany J, Tilbery CP, Mendonça RA, Melo ACP. Prevalence of multiple sclerosis in the city of São Paulo, Brazil in 1990. Neuroepidemiology 1992;11:11-14.
16. Papais-Alvarenga RM, Santos CMM, Bernadini JSA, Camargo SMGG. Esclerose múltipla:perfil clínico e epidemiológico no Rio de Janeiro. Arq Neuropsiquiatr 1990;48(Supl):63A.
17. Martyn C. The epidemiology of multiple sclerosis. In Matthews WB, Compston A, Allen IV, Martyn CD (eds). McAlpine's multiple sclerosis, 2.ed. New York: Churchill Livingstone, 1991:3-42.
18. Lana-Peixoto MA, Lana-Peixoto MI. Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 1992;50:419-425.
19. ∧.
20. Rolak LA. The diagnosis of Multiple sclerosis. Neurol Clinic 1996;14:27-42.
21. Tilbery CP, Felipe E, Baldauf CM, Peres MFP. Esclerose múltipla: análise clínica e evolutiva de 214 casos. Arq Neuropsiquiatr 1995;53:203-207.
22. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-134.
23. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
24. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428.
25. Weinshenker BG, Bass B, Rice GPA, et al The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-1056.
26. Mattews WB. Clinical aspects. In Matthews WB, Compston A, Allen IV, Martyn CN (eds). Mc Alpine's multiple sclerosis. 21.ed. Edinburgh: Churchill Livingstone, 1991:P231-250.
27. McAlpine D. The benign form of multiple sclerosis: a study based on 241 cases seen within 3 years of onset and followed up until the 10h year or more of the disease. Brain 1961;84:186-203.
28. Mc Alpine D. The benign form of multiple sclerosis: results of a long-term sludy. Br Med J 1964;2:1029-1032.
29. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin 1995;14:291-308.